National Health Investors, Inc. (NYSE:NHI) declared a quarterly dividend on Tuesday, December 15th, Zacks reports. Investors of record on Thursday, December 31st will be paid a dividend of 1.102 per share by the real estate investment trust on Friday, January 29th. This represents a $4.41 dividend on an annualized basis and a yield of 6.41%. The ex-dividend date is Wednesday, December 30th.
National Health Investors has increased its dividend payment by 16.7% over the last three years and has increased its dividend annually for the last 10 consecutive years.
Shares of NYSE NHI opened at $68.75 on Wednesday. The firm has a market cap of $3.08 billion, a PE ratio of 16.14 and a beta of 0.85. The company has a current ratio of 13.13, a quick ratio of 13.13 and a debt-to-equity ratio of 1.02. National Health Investors has a 1-year low of $31.37 and a 1-year high of $91.12. The company has a fifty day moving average price of $63.28 and a 200 day moving average price of $61.74.
National Health Investors (NYSE:NHI) last announced its earnings results on Monday, November 9th. The real estate investment trust reported $0.95 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.43 by ($0.48). The company had revenue of $84.30 million during the quarter, compared to analyst estimates of $82.87 million. National Health Investors had a return on equity of 12.64% and a net margin of 56.94%. National Health Investors’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same period in the previous year, the company posted $1.42 earnings per share. Equities research analysts forecast that National Health Investors will post 5.63 EPS for the current year.
Massive green paydays could be on the way for cannabis companies inside California’s Cannabis Supercluster. The legal cannabis business is blazing in the Bay Area. Find out how Juva Life (OTC: JUVAF) is capitalizing on this boom.
In other news, Director Robert G. Adams bought 1,000 shares of the company’s stock in a transaction dated Tuesday, November 17th. The shares were bought at an average cost of $66.45 per share, with a total value of $66,450.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Robert G. Adams bought 2,000 shares of the company’s stock in a transaction dated Monday, December 14th. The stock was purchased at an average cost of $67.75 per share, for a total transaction of $135,500.00. The disclosure for this purchase can be found here. 5.74% of the stock is currently owned by corporate insiders.
NHI has been the subject of a number of research analyst reports. Stifel Nicolaus reaffirmed a “hold” rating and issued a $63.00 target price on shares of National Health Investors in a research note on Tuesday, September 1st. ValuEngine downgraded shares of National Health Investors from a “hold” rating to a “sell” rating in a research note on Thursday, October 1st. Zacks Investment Research upgraded shares of National Health Investors from a “sell” rating to a “hold” rating in a research note on Thursday, November 19th. Berenberg Bank downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, December 2nd. Finally, KeyCorp upgraded shares of National Health Investors from an “underweight” rating to a “sector weight” rating in a research note on Monday. One equities research analyst has rated the stock with a sell rating and nine have issued a hold rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $65.88.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Recommended Story: How to interpret the current ratio
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
The stock market has been growing since the New York Stock Exchange opened its doors in 1817. Sometimes, a stock will outpace the rest of the market in terms of growth. These skyrocketing securities—or the ones that analysts expect to skyrocket—are called growth stocks.
What Every Investor Needs to Know About Growth Stocks
Growth stocks are a great opportunity for an investor to make money in the stock market, but you’ve got to know what you’re going to buy or sell. A good understanding of growth stocks will help you get there.
At the beginning of a bull market, you can almost choose stocks randomly and find yourself a winner. Now that we are entering the current bull market’s ninth year, growth stocks have appreciated considerably. It’s becoming far more challenging to find stocks with real opportunities for appreciation.
Growth companies are still largely outperforming their value counterparts in the United States and the rest of the world largely because of low-interest rates, improved corporate earnings, and global economic growth. Over the last five years, the S&P 500 Growth Index has returned 14.22% per year. During the same time, the S&P 500 Value Index returned just 12.94%.
Now that the bull market is now nearly a decade old, stocks have become very expensive. Value investors are largely sitting on the sidelines, and growth investors have a hard time figuring out where the remaining growth opportunities exist.
If you are looking for growth stocks in an increasingly small field, we have identified the 10 best growth stocks to buy right now based on their expected earnings growth over the next several years. These companies are all growing rapidly and will likely see double-digit earnings growth next year.